Atea Pharmaceuticals, Inc (AVIR)

Etorro trading 970x250

About Atea Pharmaceuticals, Inc

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for severe viral diseases. The company’s lead product candidate is AT-527, a novel antiviral agent for the treatment of patients infected with severe acute respiratory syndrome coronavirus 2 and is under phase 3 clinical trial. It also develops AT-787 which is under phase 2 clinical for the treatment of hepatitis C virus; AT-752 which is under phase 2 clinical trial for the treatment of dengue; and AT-889, AT-934, and other product candidates for the treatment of respiratory syncytial virus are under phase 2 clinical trials. The company was incorporated in 2012 and is based in Boston, Massachusetts. Address: 125 Summer Street, Boston, MA, United States, 02110

Atea Pharmaceuticals, Inc News and around…

Latest news about Atea Pharmaceuticals, Inc (AVIR) common stock and company :

J.P. Morgan’s Bullish Stance on Atea Pharmaceuticals Stock Comes to an End
21 Oct, 2021 Yahoo! Finance

Almost two years after Covid-19 made its unwelcome entrance, the pandemic is still presenting opportunities for companies looking to stunt its progress. Merck appears to have taken the opportunity by the horns after its antiviral oral Covid-19 treatment impressed in clinical trials and appeared to reduce the hospitalization risk by half. The pharma giant is not the only company seeking to provide patients with an alternative to more intrusive treatments. Atea Pharmaceuticals (AVIR) has also been

Expert Ratings For Atea Pharmaceuticals
20 Oct, 2021 FinancialContent

Over the past 3 months, 5 analysts have published their opinion on Atea Pharmaceuticals (NASDAQ:AVIR) stock. These analysts are ...

Atea (AVIR) Plunges on Oral COVID Candidate Study Failure
20 Oct, 2021 Yahoo! Finance

Atea (AVIR) is developing an oral drug candidate, AT-527, as a potential treatment for COVID-19 in outpatients as well as hospitalized settings in several studies.

Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2021
20 Oct, 2021 FinancialContent

Upgrades For Iridium Communications Inc (NASDAQ:IRDM), BWS Financial upgraded the previous rating of Neutral to Buy. Iridium ...

Atea Reveals Topline Results of Phase 2 MOONSONG Trial; Shares Crash 66%
20 Oct, 2021 Yahoo! Finance

Shares of Atea Pharmaceuticals (AVIR) plunged 66% on Tuesday to close at $13.82 after the clinical-stage biopharmaceutical company provided update and topline results of the Phase 2 MOONSONG trial. Notably, the trial was evaluating AT-527 in the outpatient setting. The global Phase 2 MOONSONG trial, a randomized, double-blind, multi-center, placebo-controlled trial, was evaluating the antiviral activity, safety and pharmacokinetics of AT-527 550 mg and 1,100 mg, which was administered twice dail

Implied VBR Analyst Target Price: $200
20 Oct, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Small-Cap Value ETF (VBR), we found that the implied analyst target price for the ETF based upon its underlying holdings is $200.33 per unit.

10 Biggest Price Target Changes For Wednesday
20 Oct, 2021 FinancialContent

Mizuho cut QUALCOMM Incorporated (NASDAQ: QCOM) price target from $180 to $165. QUALCOMM shares fell 0.3% to $132.13 in pre-market ...

52 Biggest Movers From Yesterday
20 Oct, 2021 FinancialContent

Gainers Xiaobai Maimai Inc. (NASDAQ: HX) shares climbed 42.6% to close at $9.51 on Tuesday. Xiaobai Maimai said Xiaobao ...

Atea Pharma Stock Crashes After Merck-Rivaling Covid Pill Lags In Midstage Test
19 Oct, 2021 FinancialContent

Atea Pharmaceuticals said Tuesday its Merck-rivaling antiviral Covid pill missed in a midstage test, leading AVIR stock to crash.

Noteworthy Tuesday Option Activity: MSTR, VIRT, AVIR
19 Oct, 2021 FinancialContent

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in MicroStrategy Inc. (MSTR), where a total volume of 15,529 contracts has been traded thus far today, a contract volume which is representative of approximately 1.6 million underlying shares (given that every 1 contract represents 100 underlying shares)..

Mid-Afternoon Market Update: Dow Surges Over 100 Points; Harmony Biosciences Shares Spike Higher
19 Oct, 2021 FinancialContent

Toward the end of trading Tuesday, the Dow traded up 0.33% to 35,374.03 while the NASDAQ rose 0.54% to 15,103.67. The S&P also rose, ...

Why Ulta and Atea Rained on the Nasdaq's Parade Tuesday
19 Oct, 2021 FinancialContent

Even with downward pressure from these two stocks, the Nasdaq Composite moved higher again.

12 Health Care Stocks Moving In Tuesday's Intraday Session
19 Oct, 2021 FinancialContent

Gainers Redhill Biopharma (NASDAQ:RDHL) stock increased by 18.27% to $5.76 during Tuesday's regular session. Redhill ...

Mid-Day Market Update: Silver Surges 3%; Galera Therapeutics Shares Plunge
19 Oct, 2021 FinancialContent

Midway through trading Tuesday, the Dow traded up 0.47% to 35,423.05 while the NASDAQ rose 0.59% to 15,110.79. The S&P also rose, ...

33 Stocks Moving In Tuesday's Mid-Day Session
19 Oct, 2021 Yahoo! Finance

Gainers HCW Biologics Inc. (NASDAQ: HCWB) surged 31% to $3.75. Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) jumped 28.9% to $2.0750 after surging 18% on Monday. Kaival Brands Innovations recently announced plans to launch distribution of its products in the U.K. Full Truck Alliance Co. Ltd. (NYSE: YMM) rose 15% to $16.54. iQIYI, Inc. (NASDAQ: IQ) shares gained 13.5% to $9.65. InflaRx N.V. (NASDAQ: IFRX) shares climbed 13.2% to $2.7387 after the company announced it was awarded an up to r

Atea Pharmaceuticals is Now Oversold (AVIR)
19 Oct, 2021 FinancialContent

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

Why Atea Pharmaceuticals Is Imploding Today
19 Oct, 2021 FinancialContent

The company's oral COVID-19 treatment looks like a dud in the mild-to-moderate COVID-19 setting.

WATT Stock: The Big FCC News That Has Energous Shares Charging Higher Today
19 Oct, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Energous (WATT) stock is getting a boost on Tuesday after announcing approval from the FCC for its wireless power technology. The post WATT Stock: The Big FCC News That Has Energous Shares Charging Higher Today appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

Mid-Morning Market Update: Markets Open Higher; Johnson & Johnson Boosts FY21 Guidance
19 Oct, 2021 FinancialContent

Following the market opening Tuesday, the Dow traded up 0.29% to 35,361.89 while the NASDAQ rose 0.31% to 15,068.75. The S&P also ...

Atea Pharmaceuticals stock rocked after disappointing trial results of SARS-CoV-2 pill
19 Oct, 2021 Yahoo! Finance

Shares of Atea Pharmaceuticals Inc. took a 70.7% nosedive on heavy volume toward a record low in morning trading Tuesday, after the biopharmaceutical company said a Phase 2 trial of its oral treatment of SARS-CoV-2 virus in an outpatient setting failed to meet its primary endpoint. Trading volume swelled to 21.6 million shares, compared with the full-day average of about 2.7 million shares. The company said primary endpoint of the AT-527 study was a reduction from baseline of SARS-CoV-2 in patie

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
19 Oct, 2021 FinancialContent

Gainers Entasis Therapeutics Hldg (NASDAQ:ETTX) shares moved upwards by 16.72% to $3.63 during Tuesday's pre-market ...

Why Are Atea Pharmaceuticals Shares Plunging Today?
19 Oct, 2021 FinancialContent

Atea Pharmaceuticals Inc(NASDAQ: AVIR)has reported datafrom the Phase 2 MOONSONG trial of AT-527 in the outpatient ...

Atea Pharmaceuticals Provides Update and Topline Results for Phase 2 MOONSONG Trial Evaluating AT-527 in the Outpatient Setting
19 Oct, 2021 Yahoo! Finance

Topline Phase 2 MOONSONG trial results did not meet the primary endpoint in the overall population of patients with mild or moderate COVID-19, who were mostly low-risk with mild symptoms In high-risk patients with underlying health conditions, a reduction of viral load of approximately 0.5 log10 at Day 7 was observed at 550 mg (prespecified subgroup analysis) and 1,100 mg BID (exploratory subgroup analysis) compared with placebo Informed by results from MOONSONG, in addition to the positive inte

Atea Pharma Stock Plunges After COVID Treatment Trial Disappoints; Merck Jumps
19 Oct, 2021 Yahoo! Finance

Atea Pharmaceuticals could shed more than $2 billion in value Tuesday after the drugmaker said a mid-stage trial of its developing COVID treatment failed to meet expectations.

Vaccine Makers Slump As Oral Antivirals Begin To Take Center Stage
18 Oct, 2021 FinancialContent

Vaccine makers have been under tremendous selling pressure over the past 2 months driven by policy, the rising delta wave, and breakthrough infections. This slump has been a boost for the oral antivirals

3 Stocks to Consider if the October Stock Market Sell-Off Worsens
17 Oct, 2021 FinancialContent

These stocks could be attractive at discounted prices.

3 COVID-19 Pill Stocks to Watch
16 Oct, 2021 FinancialContent

These big drugmakers could soon compete against each other with oral COVID-19 therapies.

The Next Challenge For Covid Stocks Is Also A Cash Cow For These Companies
15 Oct, 2021 FinancialContent

The delta variant's grip on the country has created a gargantuan challenge for companies working on desperately needed treatments, and for Covid stocks.

The success of Merck’s antiviral—and other COVID-19 pills in development—may depend on how quickly people start taking them
14 Oct, 2021 FinancialContent

Researchers are hopeful that these pills may also be able to reduce how long someone is infectious or sick—or even prevent people from ending up with long COVID.

3 COVID Stocks That Can Turn $1,000 Into $10,000
12 Oct, 2021 FinancialContent

Our trio of contributors offer three COVID-19 stocks that will zoom higher, even as we emerge from the pandemic.

Atea Pharmaceuticals, Inc (AVIR) is a NASDAQ Common Stock listed in , ,

970x250